Clinical trials
Phase 2 Uterine Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2012 | 2 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Terminated | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Elevation Oncology | 1 |
| Fore Biotherapeutics | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| University of Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Neoplasms | 6 |
| Endometrial Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Cholangiocarcinoma | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Bile Duct Neoplasms | 1 |
| Biliary Tract Neoplasms | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.